The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death
Abstract
BACKGROUND: Aprotinin (Trasylol) is used to mitigate bleeding during coronary-artery bypass grafting (CABG). Accumulating evidence suggests that this practice increases mortality. METHODS: Using electronic administrative records of the Premier Perspective Comparative Database, we studied hospitalized patients with operating-room charges for the use of aprotinin (33,517 patients) or aminocaproic acid (44,682 patients) on the day CABG was performed. We tabulated the numbers of patients with a hospital-discharge status of death and performed three types of analyses: a multivariable logistic-regression analysis (primary analysis); propensity-score matching in the highly selected subcohort of patients who received full amounts of the study drug, who underwent CABG by surgeons who performed 50 or more CABG surgeries during the study period, and for whom information on 10 additional covariates was available because the surgery occurred on hospital day 3 or later; and an instrumental-variable analysis of data from patients whose surgeons showed a strong preference for one of the two study drugs. RESULTS: In all, 1512 of the 33,517 aprotinin recipients (4.5%) and 1101 of the 44,682 aminocaproic acid recipients (2.5%) died. After adjustment for 41 characteristics of patients and hospitals, the estimated risk of death was 64% higher in the aprotinin group than in the aminocaproic acid group (relative risk, 1.64; 95% confidence interval [CI], 1.50 to 1.78). In the first 7 days after surgery, the adjusted relative risk of in-hospital death in the aprotinin group was 1.78 (95% CI, 1.56 to 2.02). The relative risk in a propensity-score-matched analysis was 1.32 (95% CI, 1.08 to 1.63). In the instrumental-variable analysis, the use of aprotinin was found to be associated with an excess risk of death of 1.59 per 100 patients (95% CI, 0.14 to 3.04). Postoperative revascularization and dialysis were more frequent among recipients of aprotinin than among recipients of aminocaproic acid. CONCLUSIONS: Patients who received aprotinin alone on the day of CABG surgery had a higher mortality than patients who received aminocaproic acid alone. Characteristics of neither the patients nor the surgeons explain the difference, which persisted through several approaches to control confounding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Identification of Causal Effects Using Instrumental Variables
Angrist, J. D., Imbens, G. W., & Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476902 · Cited by 4,230
Roques, F. (1999) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(99)00106-2 · Cited by 1,759
The Risk Associated with Aprotinin in Cardiac Surgery
Mangano, D. T., Tudor, I. C., & Dietzel, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051379 · Cited by 1,099
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
Henry, D. A., Carless, P. A., Moxey, A. J., O’Connell, D. L., Stokes, B., Fergusson, D. A., & Ker, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001886.pub4 · Cited by 1,065
Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery
Lindenauer, P. K., Pekow, P., Wang, K., Mamidi, D. K., Gutierrez, B., & Benjamin, E. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041895 · Cited by 862
Public Reporting and Pay for Performance in Hospital Quality Improvement
Lindenauer, P. K., Remus, D., Roman, S., Rothberg, M. B., Benjamin, E. M., Ma, A., & Bratzler, D. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064964 · Cited by 854
Schneeweiss, S. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1200 · Cited by 727
Self-citationThe society of thoracic surgeons: 30-day operative mortality and morbidity risk models
Shroyer, A. L. W., Coombs, L. P., Peterson, E. D., Eiken, M. C., DeLong, E. R., Chen, A., Ferguson, T. B., Grover, F. L., & Edwards, F. H. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)00179-6 · Cited by 662
Lipid-Lowering Therapy and In-Hospital Mortality Following Major Noncardiac Surgery
Lindenauer, P. K. (2004) · JAMA · doi:10.1001/jama.291.17.2092 · Cited by 474
Mortality Associated With Aprotinin During 5 Years Following Coronary Artery Bypass Graft Surgery
Mangano, D. T. (2007) · JAMA · doi:10.1001/jama.297.5.471 · Cited by 395
Brookhart, M. A., Wang, P. S., Solomon, D. H., & Schneeweiss, S. (2006) · Epidemiology · doi:10.1097/01.ede.0000193606.58671.c5 · Cited by 341
Self-citationKarkouti, K., Beattie, W. S., Dattilo, K. M., McCluskey, S. A., Ghannam, M., Hamdy, A., Wijeysundera, D. N., Fedorko, L., & Yau, T. M. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00724.x · Cited by 338
Brown, J. R., Birkmeyer, N. J. O., & O’Connor, G. T. (2007) · Circulation · doi:10.1161/circulationaha.106.671222 · Cited by 304
Shapiro, S. (1997) · PubMed · Cited by 299
Sedrakyan, A., Treasure, T., & Elefteriades, J. A. (2004) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.03.041 · Cited by 279
An application of propensity score matching using claims data
Seeger, J. D., Williams, P. L., & Walker, A. M. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1062 · Cited by 218
Self-citationMunoz, J. J., Birkmeyer, N. J. O., Birkmeyer, J. D., O’Connor, G. T., & Dacey, L. J. (1999) · Circulation · doi:10.1161/01.cir.99.1.81 · Cited by 185
Avoidance of Bleeding During Surgery in Patients Receiving Anticoagulant and/or Antiplatelet Therapy
Harder, S., Klinkhardt, U., & Alvarez, J. M. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443140-00002 · Cited by 140
Schneeweiß, S., Solomon, D. H., Wang, P. S., Rassen, J. A., & Brookhart, M. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22219 · Cited by 102
van der Linden, J., Lindvall, G., & Sartipy, U. (2005) · Circulation · doi:10.1161/circulationaha.104.524611 · Cited by 95
Despotis, G. J., & Joist, J. H. (1999) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/s1053-0770(21)00594-2 · Cited by 83
West, S. L., Strom, B. L., Freundlich, B., Normand, E. H., Koch, G. G., & Savitz, D. A. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90021-3 · Cited by 79
Gunawan, B. K., & Runyon, B. A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02730.x · Cited by 70
Challenges in comparing risk-adjusted bypass surgery mortality results
Peterson, E. D., DeLong, E. R., Muhlbaier, L. H., Rosen, A. B., Buell, H., Kiefe, C. I., & Kresowik, T. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01022-6 · Cited by 54
DeLong, E. R., Coombs, L. P., Ferguson, T. B., & Peterson, E. D. (2005) · Biometrics · doi:10.1111/j.1541-0420.2005.00358.x · Cited by 6
Cited by
A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
Fergusson, D. A., Hébert, P. C., Mazer, C. D., Fremes, S., MacAdams, C., Murkin, J. M., Teoh, K., Duke, P. C., Arellano, R., Blajchman, M. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802395 · Cited by 1,152
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
Henry, D. A., Carless, P. A., Moxey, A. J., O’Connell, D. L., Stokes, B., Fergusson, D. A., & Ker, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001886.pub4 · Cited by 1,065
Registries for Evaluating Patient Outcomes: A User’s Guide
(2020) · doi:10.23970/ahrqepcregistries4 · Cited by 960
Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy
Turer, A. T., & Hill, J. A. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.032 · Cited by 634
Shrank, W. H., Patrick, A. R., & Alan Brookhart, M. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1609-1 · Cited by 630
Metadata
- Authors
- Schneeweiss, S., Seeger, J. D., Landon, J., & Walker, A. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-02-21
- Volume
- 358
- Issue
- 8
- Pages
- 771-783
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2100390758
- Cited by
- 357
- References
- 28
- FWCI
- 20.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.